4 clinical trials found.
-
A prospective long-term confirmatory follow up trial in highly sensitized patients treated with imlifidase or standard of care in the ConfIdeS (20-HMedIdeS-17) trial
A controlled, randomized, efficacy Phase 3 trial (ConfIdeS, 20-MedIdeS-17) comparing imlifidase with standard of care (SoC) in enabling highly sensitized patients to kidney transplantation is ...Phase N/A
TRIAL ROLE: Sub Investigator
-
Integrated multi-omics approaches to precision medicine in kidney disease (iMAP-Kidney)
The primary objective of the study is to establish a biorepository (tissue bank) for the storage of plasma, serum, DNA, RNA, urine, and fresh tissue ...Phase N/A TRIAL ROLE: Sub Investigator
-
Prophylaxis with Direct-acting Antivirals for Kidney Transplantation from Hepatitis C Virus-Infected Donors to Uninfected Recipients: a Randomized Controlled Trial
The purpose of this research study is to learn about the best approach to treat Hepatitis C Virus (HCV) in kidney transplant recipients.Phase N/A TRIAL ROLE: Sub Investigator
-
A Prospective Study to Evaluate the Safety and Efficacy of the 10 GE Xenokidney in Patients with End-stage Renal Disease (ESRD)
Each year, only about 27,000 kidney transplants are performed in the United States, leaving over 90,000 people with end stage renal disease (ESRD ...Phase
TRIAL ROLE: Sub Investigator
